Angelman Syndrome Neurocognitive and Linguistic Profile, Overlaps, Interventions, and Quality of Life
Document Type
Book Chapter
Source of Publication
Clinical Applications of Pediatric Neuropsychology from Infancy to Adolescence
Publication Date
1-1-2025
Abstract
Angelman Syndrome (AS) is a rare neurogenetic disorder caused by a mutation or deletion of the UBE3A gene on chromosome 15, affecting the brain's development and function. Neurocognitively, individuals with AS often exhibit significant developmental delays, with limited cognitive abilities, impaired motor coordination (ataxia), and epilepsy being common. While cognitive impairment is a hallmark of the syndrome, memory and problem- solving abilities are also significantly affected. Linguistically, AS is characterized by profound speech impairments, with most individuals developing little to no functional speech. Early diagnosis, often through genetic testing, is crucial for the implementation of early intervention programs that focus on speech therapy, physical therapy, and behavioral management. Specialized interventions that address motor deficits, language development, and behavioral concerns can enhance cognitive and social functioning, although the overall prognosis remains one of lifelong disability.
DOI Link
ISBN
[9798369396896, 9798369396919]
First Page
143
Last Page
155
Disciplines
Education | Medicine and Health Sciences
Keywords
Angelman Syndrome, neurocognitive profile, linguistic profile, interventions, quality of life
Scopus ID
Recommended Citation
Katsarou, Dimitra V.; Theodoratou, Maria; Sofologi, Maria; Kougioumtzis, Georgios; Efthymiou, Efthymia; Argyriadis, Alexandros; Patsiaouras, Asterios; Mantsos, Evangelos; Argyriadi, Agathi; and Papadopoulou, Soultana, "Angelman Syndrome Neurocognitive and Linguistic Profile, Overlaps, Interventions, and Quality of Life" (2025). All Works. 7302.
https://zuscholars.zu.ac.ae/works/7302
Indexed in Scopus
yes
Open Access
no